GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

1983 • 4,822 citations

Estimation of nuclear population from microtome sections

1946 • 4,378 citations

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

1983 • 2,149 citations

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

1985 • 1,253 citations

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

1984 • 1,007 citations

Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice

1984 • 1,005 citations

Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)

1985 • 620 citations

Biology of gangliosides: Neuritogenic and neuronotrophic properties

1984 • 314 citations

Activation of (Na⁺, K⁺)‐ATPase by Nanomolar Concentrations of GM₁ Ganglioside

1981 • 212 citations

The stimulating effect of ganglioside injections on the recovery of choline acetyltransferase and acetylcholinesterase activities in the hippocampus of the rat after septal lesions

1982 • 140 citations

Retrograde changes in the nucleus basalis of the rat, caused by cortical damage, are prevented by exogenous ganglioside GM1

1986 • 132 citations

Epinephrine: A Potential Neurotransmitter in Retina

1983 • 116 citations

1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway

1986 • 111 citations

Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum

1985 • 110 citations

Treatment with GM1 Ganglioside Restores Striatal Dopamine in the 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Treated Mouse

1988 • 98 citations

Effect of GM₁ ganglioside treatment on the recovery of dopaminergic nigro‐striatal neurons after different types of lesion

1984 • 90 citations

Administration of GMI. ganglioside restores the dopamine content in striatum after chronic treatment with MPTP

1986 • 86 citations

GM1 ganglioside enhances regrowth of noradrenaline nerve terminals in rat cerebral cortex lesioned by the neurotoxin 6-hydroxydopamine

1984 • 83 citations

Parenterally administered GM1 ganglioside prevents retrograde degeneration of cholinergic cells of the rat basal forebrain

1986 • 73 citations

Effect of GM1 ganglioside on neonatally neurotoxin induced degeneration of serotonin neurons in the rat brain

1984 • 61 citations

Ganglioside interactions with the dopaminergic system of rats

1988 • 38 citations

Neural plasticity of basal forebrain cholinergic neurons: effects of gangliosides

1987 • 36 citations

Administration of GM1 ganglioside eliminates neuroleptic-induced sensorimotor deficits in MPTP-treated mice

1988 • 34 citations

GM1 ganglioside protects against the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐ induced degeneration of nigrostriatal dopamine neurons in the black mouse

1988 • 29 citations

Effects of neurotoxic and mechanical lesions of the mesostriatal dopamine pathway on striatal polyamine levels in the rat: Modulation by chronic ganglioside GM1 treatment

1985 • 28 citations